PeriVision
PrivateLast Round
Seed
Sep 12, 2025
Company Overview
PeriVision is a medtech company that has developed a platform using artificial intelligence, virtual reality, and cloud computing to diagnose and monitor eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Vertical SaaS, AR/VR Experiences
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PeriVision Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PeriVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 12, 2025 | ||||
| Seed | May 1, 2023 | ||||
| Debt | Apr 6, 2023 | ||||
| Pre Seed | Dec 15, 2021 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 5282% MoM, from 28 to 1.5K.
- Jan 2, 2026
Monthly visitors increased 407% MoM.
PeriVision Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PeriVision's valuation, stock price, and market status.